Institutional Ownership Aclaris Therapeutics, Inc. (ACRS)
This table provides information about the institutional ownership of Aclaris Therapeutics, Inc. (ACRS). We have compiled data on the 85 institutions that hold shares in the stock, with a total of 50.7 Million shares, which have been reported (via 13F filing form) to have a value of $111 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Bml Capital Management, LLC
Zionsville, IN |
Nov 05, 2024 Q3 2024 |
14,250,000
shares
|
$29.2 Million
9.64% of portfolio
|
Q3 2024
Added 9.72%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
4,685,498
shares
|
$9.61 Million
0.0% of portfolio
|
Q3 2024
Reduced 0.04%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2024 Q3 2024 |
3,371,849
shares
|
$6.91 Million
0.0% of portfolio
|
Q3 2024
Added 1.56%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
3,005,598
shares
|
$6.16 Million
0.0% of portfolio
|
Q3 2024
Reduced 9.93%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
2,753,495
shares
|
$5.64 Million
0.11% of portfolio
|
Q1 2024
Reduced 8.17%
|
|
|
Stonepine Capital Management, LLC
Bend, OR |
Nov 13, 2024 Q3 2024 |
2,458,873
shares
|
$5.04 Million
1.79% of portfolio
|
Q3 2024
Added 27.57%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
2,078,287
shares
|
$4.26 Million
0.01% of portfolio
|
Q3 2024
Added 8.61%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,032,155
shares
|
$4.17 Million
0.0% of portfolio
|
Q2 2024
Reduced 60.94%
|
|
|
Trium Capital LLP
London, X0 |
Oct 07, 2024 Q3 2024 |
1,912,990
shares
|
$3.92 Million
0.63% of portfolio
|
Q3 2024
Added 1.11%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
1,370,700
shares
|
$2.81 Million
0.0% of portfolio
|
Q3 2024
Added 48.63%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2024 Q3 2024 |
1,301,500
shares
|
$2.67 Million
0.0% of portfolio
|
Q3 2024
Reduced 9.42%
|
|
|
Aldebaran Capital, LLC
Indianapolis, IN |
Nov 13, 2024 Q3 2024 |
1,043,152
shares
|
$2.14 Million
1.1% of portfolio
|
Q3 2024
Added 21.56%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2024 Q3 2024 |
923,313
shares
|
$1.89 Million
0.0% of portfolio
|
Q2 2024
Reduced 3.52%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Nov 14, 2024 Q3 2024 |
915,509
shares
|
$1.88 Million
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
907,916
shares
|
$1.86 Million
0.0% of portfolio
|
Q3 2024
Reduced 18.43%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
846,446
shares
|
$1.74 Million
0.0% of portfolio
|
Q3 2024
Added 9.34%
|
|
|
Samsara Bio Capital, LLC
Palo Alto, CA |
Nov 14, 2024 Q3 2024 |
696,171
shares
|
$1.43 Million
0.46% of portfolio
|
Q1 2023
New holding
|
|
|
Acuitas Investments, LLC
|
Nov 06, 2024 Q3 2024 |
578,139
shares
|
$1.19 Million
0.31% of portfolio
|
Q3 2024
Added 24.57%
|
|
|
Palo Alto Investors LP
Palo Alto, CA |
Nov 14, 2024 Q3 2024 |
569,832
shares
|
$1.17 Million
0.09% of portfolio
|
Q1 2024
New holding
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
480,773
shares
|
$985,584
0.0% of portfolio
|
Q3 2024
Added 158.0%
|
|
|
Aisling Capital Management LP
New York, NY |
Nov 13, 2024 Q3 2024 |
434,455
shares
|
$890,632
0.2% of portfolio
|
Q4 2022
Reduced 31.52%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
364,567
shares
|
$747,362
0.0% of portfolio
|
Q3 2024
Reduced 58.35%
|
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Nov 08, 2024 Q3 2024 |
332,406
shares
|
$681,432
0.0% of portfolio
|
Q3 2024
Added 187.6%
|
|
|
High Tower Advisors, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
305,814
shares
|
$626,918
0.0% of portfolio
|
Q3 2024
Reduced 2.21%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
301,556
shares
|
$618,189
0.0% of portfolio
|
Q3 2024
Reduced 67.1%
|